## GNBR

https://zenodo.org/record/3459420#.XZ3BZOdKjUI

### chemical-gene

- (A+) agonism, activation
- (A-) antagonism, blocking
- (B) binding, ligand (esp. receptors)
- (E+) increases expression/production
- (E-) decreases expression/production
- (E) affects expression/production (neutral)
- (N) inhibits

### gene-chemical

- (O) transport, channels
- (K) metabolism, pharmacokinetics
- (Z) enzyme activity

### chemical-disease

- (T) treatment/therapy (including investigatory)
- (C) inhibits cell growth (esp. cancers)
- (Sa) side effect/adverse event
- (Pr) prevents, suppresses
- (Pa) alleviates, reduces
- (J) role in disease pathogenesis

### disease-chemical

- (Mp) biomarkers (of disease progression)

### gene-disease

- (U) causal mutations
- (Ud) mutations affecting disease course
- (D) drug targets
- (J) role in pathogenesis
- (Te) possible therapeutic effect
- (Y) polymorphisms alter risk
- (G) promotes progression

### disease-gene

- (Md) biomarkers (diagnostic)
- (X) overexpression in disease
- (L) improper regulation linked to disease

### gene-gene

- (B) binding, ligand (esp. receptors)
- (W) enhances response
- (V+) activates, stimulates
- (E+) increases expression/production
- (E) affects expression/production (neutral)
- (I) signaling pathway
- (H) same protein or complex
- (Rg) regulation
- (Q) production by cell population

## DrugBank

## Hetionet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640425/table/table2/?report=objectonly
